What’s New?
The April 2016 website update includes the following changes and additions. Thank you for visiting the ECDGA webpage!
- Six new Studies & Trials have been announced at MD Anderson in Houston, TX. Also, the NIH Phase 2 Therapeutic Trial of the Use of Dabrafenib and Trametinib was updated with links and additional information.
- Three new Care Centers were announced since the last update. A new US center is located in Missouri. International additions include Lebanon and Brazil.
- Press Releases highlighting the new ECD Care Centers, fundraisers and Rare Disease Day activities and proclamations are available.
- New fundraiser success and examples from the recent Rare Disease Day events are included on Host Fundraisers.
- Two journal articles written about ECD have become available online. View 2016 additions, Detection of an NRAS mutation in Erdheim-Chester disease and Recurrent RAS and PIK3CA mutations in Erdheim-Chester disease, in Medical Journal Articles.
- Updated the contact information for Ophthalmologist Kleanthis Manousaridis, MD PhD in Knowledgeable Doctors.
- An ECD Awareness Week page has been created to help the community learn more about this special occasion and how to make this year’s event simple and effective.